These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35509443)

  • 1. Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.
    Wijsenbeek M; Molina-Molina M; Chassany O; Fox J; Galvin L; Geissler K; Hammitt KM; Kreuter M; Moua T; O'Brien EC; Slagle AF; Krasnow A; Reaney M; Baldwin M; Male N; Rohr KB; Swigris J; Antoniou K
    ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35509443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease.
    Swigris J; Cutts K; Male N; Baldwin M; Rohr KB; Bushnell DM
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34046493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties.
    Lemmers JMJ; Vonk MC; van den Ende CHM
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36543348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases.
    Swigris JJ; Bushnell DM; Rohr K; Mueller H; Baldwin M; Inoue Y
    BMJ Open Respir Res; 2022 Mar; 9(1):. PubMed ID: 35241434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.
    Joung KI; Park H; Park S; Shin JY; Kim YH
    BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD).
    Copeland CR; Lancaster LH
    Front Med (Lausanne); 2021; 8():743977. PubMed ID: 34722582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE.
    Nakshbandi G; Moor CC; Antoniou K; Cottin V; Hoffmann-Vold AM; Koemans EA; Kreuter M; Molyneaux PL; Wuyts WA; Wijsenbeek MS
    BMC Pulm Med; 2023 Feb; 23(1):51. PubMed ID: 36732734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD.
    Shumar JN; Chandel A; King CS
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
    Kwon BS; Choe J; Chae EJ; Hwang HS; Kim YG; Song JW
    Respir Res; 2021 Oct; 22(1):282. PubMed ID: 34719401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.
    Patel AS; Siegert RJ; Brignall K; Gordon P; Steer S; Desai SR; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Thorax; 2012 Sep; 67(9):804-10. PubMed ID: 22555278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Progressive-Fibrosing Interstitial Lung Diseases.
    Cottin V; Teague R; Nicholson L; Langham S; Baldwin M
    Front Med (Lausanne); 2022; 9():799912. PubMed ID: 35178411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases.
    Birring SS; Bushnell DM; Baldwin M; Mueller H; Male N; Rohr KB; Inoue Y
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspective of progressive-fibrosing interstitial lung disease.
    Kishaba T
    Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function trajectory in progressive fibrosing interstitial lung disease.
    Oldham JM; Lee CT; Wu Z; Bowman WS; Pugashetti JV; Dao N; Tonkin J; Seede H; Echt G; Adegunsoye A; Chua F; Maher TM; Garcia CK; Strek ME; Newton CA; Molyneaux PL
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.